F. Liang

发表

The influence of 18F-fluorodeoxyglucose positron emission tomography/computed tomography on the N- and M-staging and subsequent clinical management of intrahepatic cholangiocarcinoma

Y. Lin, M. Zeng, Jia Fan, 2021, Hepatobiliary surgery and nutrition.

56P Anti-PD1 antibody toripalimab, lenvatinib and gemox chemotherapy as first-line treatment of advanced and unresectable intrahepatic cholangiocarcinoma: A phase II clinical trial

Yingyong Hou, S. Qiu, Yang Xu, 2020 .

Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma.

J. Yun, Q. Gao, Jia Fan, 2021, Journal of hepatology.

Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study

S. Qiu, Jian Zhou, Jian Sun, 2023, Signal Transduction and Targeted Therapy.

Lenvatinib plus toripalimab as first-line treatment for advanced intrahepatic cholangiocarcinoma: A single-arm, phase 2 trial.

Q. Ye, S. Qiu, Jia Fan, 2021 .

Gemox chemotherapy in combination with anti-PD1 antibody toripalimab and lenvatinib as first-line treatment for advanced intrahepatic cholangiocarcinoma: A phase 2 clinical trial.

S. Qiu, Q. Gao, Jia Fan, 2021 .

Safety and immunogenicity of a modified COVID-19 mRNA vaccine, SW-BIC-213, as a heterologous booster in healthy adults: an open-labeled, two-centered and multi-arm randomised, phase 1 trial

M. Shen, F. Zhu, Jia Fan, 2023, eBioMedicine.

Tumor Radiomic Features on Pretreatment MRI to Predict Response to Lenvatinib plus an Anti-PD-1 Antibody in Advanced Hepatocellular Carcinoma: A Multicenter Study

Haifeng Zhao, M. Zeng, Jia Fan, 2022, Liver Cancer.